🦊/Investors

Cobro Ventures

Venture capital

Mclean · Seed–Series A · 3 people tracked

Find your way into Cobro Ventures

320 people in our graph share verified history with the Cobro Ventures team — schools, employers, funds. One of them is your warm intro.

Wesley Chanunlockedknows Todd Kaloudis · together at Massachusetts Institute of Technology (overlapped)
×10knows the team · via Massachusetts Institute of Technology
knows the team · via MIT Sloan School of Management
Fox Verdict
Sign up to see your fit

Investment thesis

Cobro Ventures invests in technology and biotech businesses, drawing on a 25+ year track record as founders, operators, and investors with multiple exits through IPO and M&A. Launched by the entrepreneurs behind OPNET Technologies, the firm embraces a 'doing well by doing good' philosophy. It seeks high-impact opportunities, backs world-class scientific and technology experts, and leverages its experience with intellectual property and strategic business development to build significant value.

Source: firm website, verified Sep 15, 2026.

Stage
Seed–Series A
HQ
Mclean, Virginia, US
Instruments
Equity
Founded
2013
Private fund assets
$76M
VC funds
2
Tracked investments
7
Unicorns
1
IPOs
1

Team · 3 people

from public directories

Founder mafia

2 people who came through Cobro Ventures went on to found or lead other companies.

What they invest in

from 6 of 7 portfolio companies

Biotech ×6AI & Machine Learning ×1Deep Tech ×1Hardware ×1Medical Devices ×1

HQs:United States×6

Investments · 7 tracked

founders shown can be your intro path

By year:2023 · 12022 · 42018 · 12015 · 17 dated

C4 Therapeuticsc4therapeutics.comin𝕏NASDAQ: CCCCSeries A · Dec 2015 · $73M

C4 Therapeutics develops targeted protein degradation medicines aimed at treating disease.

BiotechCambridge, US

Kenneth C. Anderson(Director)Andrew J. Hirsch(Director and Chief Executive Officer)in

BoardMarc Cohen(Executive Officer, Director)inJason Fisherman(Executive Officer, Director)Miles Stuchin(Director)Bruce Downey(Director)

Co-investors3E Bioventures CapitalBain Capital Life SciencesNextech InvestRA Capital

AI Proteinsaiproteins.bioin𝕏Seed · Jul 2023 · $18M

AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry.

AI & Machine LearningBiotechDeep TechAndover, US

Chris Bahl(Executive Officer, Director)inDominique Verhelle(Director)Bill McKee(Director)Julia Novina(Executive Officer)Marc A. Cohen(Executive Officer, Director)inGeoff Meyerson(Director)

Board seatTodd Kaloudis· per SEC Form D

Co-investorsMission BiocapitalTachyon Ventures

Windgap Medicalwindgapmedical.cominJan 2022 · $39M

Windgap Medical designs autoinjector devices for delivering complex drugs and combination products, including systems for reconstituting lyophilized or powdered compounds, sequential delivery of two liquid therapies, high-viscosity medications, and large-volume injections.

BiotechHardwareMedical DevicesWatertown, US

Brent Buchine(Director)inMax Meehan(Executive Officer)inAaron Mann(Executive Officer, Director)inJason Durkin(Executive Officer)inJohn Cadigan(Executive Officer)inAnthony Watson(Executive Officer)in

Co-investorsBantam GroupBoston Harbor AngelsColle Capital PartnersLaunchpad Venture GroupTaiwania Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Microbial Machines, Inc.NextRNA TherapeuticsMana TherapeuticsRegenacy Pharmaceuticals

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 1

1 IPOs

C4 TherapeuticsNASDAQ: CCCC

Portfolio news

latest coverage across their companies

IPO stake values · per SEC filings

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
C4 Therapeutics5.2%$37.00Jun 2021$91.9M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has Cobro Ventures made?
Cobro Ventures has 7 tracked investments, 1 of which have exited.
What stage does Cobro Ventures invest at?
Cobro Ventures invests at the Seed, Series A stages.
What sectors does Cobro Ventures focus on?
Cobro Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Enterprise Software, SaaS.
Where is Cobro Ventures located?
Cobro Ventures is headquartered in Mclean, US.

Similar investors

Featured in lists